TC
IPSC icon

Truvestments Capital’s Century Therapeutics IPSC Stock Holding History

Truvestments Capital’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71K Buy
+2,330
New +$5.32K ﹤0.01% 880

Other funds holding IPSC

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Truvestments Capital's IPSC Position: Q2 2026 in Review

Truvestments Capital opened a new position in Century Therapeutics (IPSC) in Q2 2026: 2,330 shares worth $5.71K. The stake represents ﹤0.01% of the portfolio and ranks #880 among its holdings.

100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Truvestments Capital held 2,330 shares of Century Therapeutics worth $5.71K as of Q2 2026.
  • Century Therapeutics was a new Truvestments Capital position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #880 holding.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.